5-propynylarabinofuranosyluracil has been researched along with Cytomegalovirus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bevilacqua, F; Collins, P; Darby, G; Davis-Poynter, N; Gower, D; Worrallo, J | 1 |
1 other study(ies) available for 5-propynylarabinofuranosyluracil and Cytomegalovirus
Article | Year |
---|---|
Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Base Sequence; Cytomegalovirus; Drug Evaluation, Preclinical; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Promoter Regions, Genetic; Thymidine Kinase; Transformation, Genetic; Virulence; Virus Latency | 1995 |